Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2.
Buckheit RW Jr, Watson K, Fliakas-Boltz V, Russell J, Loftus TL, Osterling MC, Turpin JA, Pallansch LA, White EL, Lee JW, Lee SH, Oh JW, Kwon HS, Chung SG, Cho EH. Buckheit RW Jr, et al. Among authors: fliakas boltz v. Antimicrob Agents Chemother. 2001 Feb;45(2):393-400. doi: 10.1128/AAC.45.2.393-400.2001. Antimicrob Agents Chemother. 2001. PMID: 11158731 Free PMC article.
Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups.
Buckheit RW Jr, Fliakas-Boltz V, Decker WD, Roberson JL, Stup TL, Pyle CA, White EL, McMahon JB, Currens MJ, Boyd MR, et al. Buckheit RW Jr, et al. Among authors: fliakas boltz v. Antiviral Res. 1995 Mar;26(2):117-32. doi: 10.1016/0166-3542(94)00069-k. Antiviral Res. 1995. PMID: 7541618
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide.
Buckheit RW Jr, Kinjerski TL, Fliakas-Boltz V, Russell JD, Stup TL, Pallansch LA, Brouwer WG, Dao DC, Harrison WA, Schultz RJ, et al. Buckheit RW Jr, et al. Among authors: fliakas boltz v. Antimicrob Agents Chemother. 1995 Dec;39(12):2718-27. doi: 10.1128/AAC.39.12.2718. Antimicrob Agents Chemother. 1995. PMID: 8593008 Free PMC article.
Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolates.
Buckheit RW Jr, Snow MJ, Fliakas-Boltz V, Kinjerski TL, Russell JD, Pallansch LA, Brouwer WG, Yang SS. Buckheit RW Jr, et al. Among authors: fliakas boltz v. Antimicrob Agents Chemother. 1997 Apr;41(4):831-7. doi: 10.1128/AAC.41.4.831. Antimicrob Agents Chemother. 1997. PMID: 9087499 Free PMC article.
Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1.
Buckheit RW Jr, Hollingshead M, Stinson S, Fliakas-Boltz V, Pallansch LA, Roberson J, Decker W, Elder C, Borgel S, Bonomi C, Shores R, Siford T, Malspeis L, Bader JP. Buckheit RW Jr, et al. Among authors: fliakas boltz v. AIDS Res Hum Retroviruses. 1997 Jun 10;13(9):789-96. doi: 10.1089/aid.1997.13.789. AIDS Res Hum Retroviruses. 1997. PMID: 9171223
Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
Buckheit RW Jr, White EL, Fliakas-Boltz V, Russell J, Stup TL, Kinjerski TL, Osterling MC, Weigand A, Bader JP. Buckheit RW Jr, et al. Among authors: fliakas boltz v. Antimicrob Agents Chemother. 1999 Aug;43(8):1827-34. doi: 10.1128/AAC.43.8.1827. Antimicrob Agents Chemother. 1999. PMID: 10428899 Free PMC article.